Adocia SAS Actions Port. EO -,10

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

16.21%

Market Cap

152.10 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.93 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE3.722 G0 Units
PRICE DETERMINATION TIME07/20/2026 / 09:56:28 PM
DAILY VOLUME (UNITS)2,157
DAILY HIGH / LOW3.863.694
PREV. DAY'S PRICE3.842 (07/17)
CHANGE DAY BEFORE
-0.12
-3.12 %
52 WEEK HIGH / LOW10.66 (10/14)3.62 (07/14)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-1.91-0.63-0.93-0.91-0.62
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
--87.98--
PRICE - SALES RATIO
59.479.5581.38--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A1JTC2
ISIN
FR0011184241
SYMBOL
A89
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
ADOCIA SAS EO -,10
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
14.08 Mil.
MARKET CAPITALISATION
152.10 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
2.95 %
-10.02 %
-24.89 %
-36.18 %
-16.21 %
0.97 %
-60.02 %
-39.69 %
HIGH3.914.475.877.3910.6614.8414.847.39
LOW3.623.623.623.623.623.002.733.62

Dividende

pro Aktie
ADOCIA SAS EO -,10 does not deliver dividend information

Company profile

Adocia SA is a clinical-stage biotechnology company, which engages in the development of medicines from already-approved therapeutic proteins and peptides. Its product pipelines include: Biochaperone Lispro, Combo, M1pram, Glucagon, Gla Glp-1, Glucagon Glp-1 & Cell Therapy. The company was founded by Gérard Soula, Olivier Soula and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.